Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

A Phase 1, Multiple Ascending Dose Glucose Clamp Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 in Comparison to Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Mellitus

This is a phase 1 multiple ascending dose (MAD) study, conducted in subjects with Type 1 and Type 2 diabetes mellitus

Inclusion Criteria:

• T1DM or T2DM
• Female subjects must be non-pregnant and non-lactating

Exclusion Criteria:

• Pregnant or lactating women
• Participation in an investigational study within 30 days prior to dosing